A hotly debated lung cancer drug cut the risk of death by 34% in a late-stage trial in China
Piotr Swat | Lightrocket | Getty Images An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial, according to results released Sunday. When combined with chemotherapy, the drug kept people with squamous […]
Health
